Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial)
This is an interventional, single-arm, open-label study with high dose short course radiotherapy for patients with locally advanced pancreatic cancer.
Trial Details
- NCT ID
- NCT05191940
- Phase
- NA
- Sponsor
- EBG MedAustron GmbH
- Status
- RECRUITING
- Cancer Type
- Pancreatic Cancer
- Interventions
- Particle-therapy using protons or carbon ions
- Blood sampling
- Magnetic resonance imaging
- Computertomography
- 18-F-FluorDesoxyGlukose Positron Emission Tomography-Computer Tomography (18F-FDG-PET-CT)
- Locations (sample)
- Wiener Neustadt, Lower Austria, Austria|47.80485,16.23196
Key Eligibility Criteria
- The patient has histologically or cytological confirmed diagnosis of pancreatic cancer (cases with radiological findings suspicious of pancreatic c…
- The patient is not candidate for radical surgical resection because of one or more of the following reasons:
- the patient is staged as locally advanced and with unresectable disease according to the international consensus definition. Specific criteria are:…
- the patient is not a candidate for radical surgery because of radiographic or biochemical (CA 19-9) progression during neoadjuvant chemotherapy des…
For full eligibility, visit ClinicalTrials.gov.